Venus Remedies Limited
Share Price Target & Analysis
NSE:VENUSREM
VWAP
Open
Close
High
Low
52 Week High
-25.00 (-1.48%)
VENUSREM
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Standard
Quality
Bronze
Valuation
#Analysis
NSE: VENUSREM Share Price Financial Analysis & Valuation
Venus Remedies Limited (VENUSREM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Micro Cap company with Market Capitalization of Rs 440.6 (in Cr). Total number of free float shares are 1.2 (in Lacs).
Venus Remedies Limited is listed on NSE with Exchange ID - INE411B01019 and trading code is NSE:VENUSREM with short name Venus Remedies.
In the past 1 year, Venus Remedies Limited has declared an equity dividend of Rs 0.6 per share. At the current share price of VENUSREM at Rs 1669.40, this results in a dividend yield of 0.04 %.
As per the Fundamental Analysis of NSE:VENUSREM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine VENUSREM underlying value and future prospects. All of this data is available in VENUSREM financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:VENUSREM, it is clearly understood that VENUSREM is Standard performer in terms of earnings and profit margins with an EPS of 92.76. NSE:VENUSREM book value per share as of today is 535.02. The current price to book ratio for VENUSREM as of Sep 07, 2026 is 3.12.
Valuation of the Stock: The current valuation of VENUSREM stock is like Bronze which means currently the stock is Reasonably Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of VENUSREM whether to BUY this stock at current valuation. The delivery percentage of VENUSREM is 0% is very crucial parameter which shows that 0% investors are anticipating that the price of VENUSREM share should go up with VWAP at 1688.5.
Now, the main question is whether to BUY or SELL, NSE:VENUSREM at current valuation.
As per latest Analysis No. #1101:-
⇑ STRONG BUY VENUSREM if All Greens
⇗ BUY VENUSREM (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD VENUSREM (With Stop Loss) if only 1 Green
⇘ SELL VENUSREM if NO Green Indicator
NSE: VENUSREM Share Price Today (Sep 07, 2026)
(Venus Remedies Limited Daily Analysis on the basis of VENUSREM Intraday Graph & Trend)
Venus Remedies Limited share price moved Down by -1.48% from its previous close of Rs 1694.4. VENUSREM stock last traded price is 1669.40. VENUSREM share price trend is Down with a total of 17771 stocks traded till now. It has touched an intraday high of Rs 1724.9 and an intraday low of Rs 1652.1. The VENUSREM trading at 1669.40, Down by Rs. -25.00, or -1.48 percent which suggests that most of the Traders are anticipating that the price of VENUSREM share should go Down.
NSE: VENUSREM Share Price Tomorrow Prediction
(Venus Remedies Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of VENUSREM)
Venus Remedies Limited share price moved Down by -1.48%. VENUSREM share price short term trend is Down. It suggests that VENUSREM Share Price for Tomorrow remains the same with VWAP at 1688.5 will be treated as stop loss for intraday traders. Venus Remedies Limited Long term investors can follow the VENUSREM long term trend as mentiond in future forecast table.
NSE Code |
NSE: VENUSREM |
VENUSREM Share Price Today |
1669.40 |
VENUSREM Share Price Target Prediction for 2026 ^ |
1191.3 - 2054.4 |
VENUSREM Share Price Target Prediction for 2027*^ |
2054.4 - 2188.6 |
VENUSREM Share Price Target Prediction for 2028*^ |
2188.6 - 2341.8 |
VENUSREM Share Price Target Prediction for 2029*^ |
2459 |
VENUSREM Share Price Target Prediction for 2030*^ |
2529 |
VENUSREM Share Price Target Prediction for 2035*^ |
2757 |
| VENUSREM Current Book Value |
532.3 |
*Venus Remedies Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^VENUSREM share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
VENUSREM Technical Analysis
Candlestick Pattern: @1600.9| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 1619.24 | SELL | 1632.72 | SELL |
| MA_12 | 1701.46 | SELL | 1656.93 | SELL |
| MA_20 | 1660.71 | SELL | 1661.05 | SELL |
| MA_32 | 1652.87 | SELL | 1655.01 | SELL |
| MA_50 | 1696.45 | SELL | 1624.03 | SELL |
| MA_100 | 1512.09 | BUY | 1502.9 | BUY |
| MA_200 | 1110.15 | BUY | 1202 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 1660.71 | Downtrend |
| MACD | -10.87 | SELL |
| ADX | 17.77 | NO or Weak Trend |
| DMI (+/-) | 17.1 / 20.64 | Downtrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 44.27 | Neutral |
| STOCHASTIC_K (Fast) | 53.96 | Neutral |
| STOCHASTIC_D (Slow) | 53.79 | Neutral |
| CCI | -87.98 | Neutral |
| PSAR | 1834.9 | SELL |
| TRUE RANGE | 77.6 | Neutral |
| ATR | 88.42 | Neutral |
| WILLIAMS R | -84.41 | Oversold |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 17.17 | Oversold |
| STOCHASTIC RSI D | 52.53 | Neutral |
| MOMENTUM | 16.8 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 233.21% |
| 3 Months | 19.11% |
| 1 Month | 1.06% |
| 1 Week | -3.41% |
| Action | Overall (%) |
|---|---|
| BUY | 17% |
| NEUTRAL / HOLD | 30% |
| SELL | 53% |
Most popular Questions & Answers about VENUSREM (/ FAQ VENUSREM)
Venus Remedies Limited stock last traded price is 1669.40. VENUSREM share price moved Down by -1.48% from its previous close of Rs 1694.4.
Venus Remedies Limited share price trend is Down with a total of 17771 stocks traded till now. It has touched an intraday high of Rs 2064.743 and an intraday low of Rs 1652.1. The VENUSREM trading at 1669.40, Down by Rs. -25.00, or -1.48 percent which suggests that most of the Traders are anticipating that the price of VENUSREM share should go Down and the Stop Loss will be around 1688.5.
The market cap of Venus Remedies Limited is ₹440.6 (in Cr) as of Sep 06, 2026.
The current price to earning ratio for Venus Remedies Limited as of Sep 06, 2026 is 19.72.
The current price to book ratio for Venus Remedies Limited as of Sep 06, 2026 is 3.12.
The highest price of Venus Remedies Limited stock is ₹2044.3 in the last 52-week.
The lowest price of Venus Remedies Limited stock is ₹424 in the last 52-week.
Venus Remedies Limited share trading at ₹1669.40, Down by Rs. -25.00, or -1.48 percent which suggests that most of the traders are anticipating that the price of VENUSREM share should go Down.
In 2026, Stock price target for Venus Remedies Limited (VENUSREM) will be around ₹1191.3 on downside and ₹2054.4 on upside. Venus Remedies Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Venus Remedies Limited (VENUSREM) will be around ₹2054.4 on downside and ₹2188.6 on upside. Venus Remedies Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Venus Remedies Limited (VENUSREM) will be around ₹2188.6 on downside and ₹2341.8 on upside. Venus Remedies Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Venus Remedies Limited (VENUSREM) will be around ₹2529 Venus Remedies Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of VENUSREM.
The price of Venus Remedies Limited (VENUSREM) shares moved by -1.48%. The short-term trend for VENUSREM share price is Down. It implies that the share price of VENUSREM will stay the same tomorrow and that intraday traders should treat VWAP at 1688.5 as a stop loss. Investors with a long-term outlook can track VENUSREM long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of VENUSREM stock is 1112.2. Compared to the current market price of 1669.40 INR, the VENUSREM stock is Overvalued by 33.4%.
As per the fundamental analysis of Venus Remedies Limited (VENUSREM), it is of Standard quality in terms of earnings and profit margins with an EPS of 92.76. Venus Remedies Limited book value per share as of today is 535.02. The current price to book ratio for VENUSREM as of Sep 07, 2026 is 3.12.
NSE:VENUSREM News & Other Useful Information about VENUSREM Share Price
Peer Comparison of NSE: VENUSREM
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1895.00 | 16.35 | 97.89 |
| DIVISLAB | 9315.00 | 115.55 | 663.06 |
| MEDICAMEQ | 279.25 | 12.15 | 208.08 |
| CIPLA | 1395.00 | 51.67 | 434.03 |
| DRREDDY | 1144.20 | 53.19 | 380.63 |
| TORNTPHARM | 4914.00 | 87.32 | 235.7 |
| BIOCON | 391.40 | 1.27 | 166.51 |
| LUPIN | 2105.00 | 154.86 | 718.37 |
| ALKEM | 5242.50 | 212.33 | 1218.48 |
| AUROPHARMA | 1660.00 | 46.49 | 403.84 |
| ABBOTINDIA | 25940.00 | 766.11 | 2448.41 |
| GLAXO | 2957.80 | 63.65 | 147.25 |
| IPCALAB | 1959.10 | 56.72 | 329.23 |
| LAURUSLABS | 1876.70 | 20.74 | 102.57 |
| LALPATHLAB | 1901.90 | 39.68 | 157.23 |
| PFIZER | 4596.50 | 170.54 | 963.41 |
| AJANTPHARM | 3513.60 | 89.3 | 363.23 |
| SANOFI | 3122.00 | 158.05 | 332.96 |
| NATCOPHARM | 838.30 | 82.14 | 481.67 |
| APLLTD | 799.55 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2451.90 | 1.24 | 881.78 |
| AAREYDRUGS | 97.31 | 2.39 | 53.38 |
| JUBLPHARMA | 950.30 | 4.35 | 145.63 |
| SPARC | 205.87 | 48.14 | 40.45 |
| GRANULES | 867.30 | 23.25 | 180.42 |
| ASTRAZEN | 6851.00 | 86.44 | 364.29 |
| CAPLIPOINT | 2814.00 | 55.52 | 285.6 |
| FDC | 342.15 | 21.19 | 161.21 |
| HIKAL | 243.00 | 9.34 | 96.63 |